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HuR, a ubiquitously expressed member of the Hu protein family that binds and stabilizes an AU-rich element (ARE)-containing
mRNAs, is known to shuttle between the nucleus and the cytoplasm via several export pathways. When normal cells were treated
with heat shock, HuR was exported to the cytoplasm in a chromosome maintenance region 1 (CRM1)-dependent manner.
However, in this study, we demonstrate that HuR is exported to the cytoplasm in oral cancer cells even if the cells were treated with
the inhibitor of the CRM1-independent export pathway. Immunohistochemical and biochemical analyses showed that HuR existed in
both the cytoplasm and the nucleus in oral cancer cells, such as HSC-3 and Ca9.22, but existed entirely inside the nucleus in normal
cells. AU-rich element-mRNAs were also exported to the cytoplasm and stabilised in the oral cancer cells, which were inhibited by
HuR knockdown. This export of HuR was not affected by at least 7h of treatment of leptomycin B (LMB), which is an inhibitor of the
CRM1-dependent export pathway. These findings suggest that HuR is exported to the cytoplasm in oral carcinoma cells in a different
manner from that of normal cells, and is likely to occur through the perturbation of a normal export pathway.
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HuR is a member of the ELAV (embryonic lethal abnormal vision)
family of RNA-binding proteins, which has three RNA recognition
motifs connected by a short hinge region (Ma et al, 1996).
Although HuR is localised predominantly in the nucleus, it is able
to shuttle between the nucleus and the cytoplasm. The export of
HuR is mediated by its association with transportin 1 (Trn1) and
Trn2 (Rebane et al, 2004) by the shuttling sequence termed ‘HNS’
in the hinge region (Fan and Steitz, 1998), and by its association
with pp32 and APRIL, which includes the nuclear export signal
recognised by the export receptor chromosome maintenance
region 1 (CRM1) (Brennan et al, 2000; Gallouzi et al, 2001). Under
physiological conditions, such as heat shock or serum stimulation,
the HuR–pp32 complex is used for the transportation of AU-rich
element (ARE)-containing mRNAs from the nucleus to the
cytoplasm (Brennan et al, 2000; Gallouzi and Steitz, 2001).
An ARE is commonly present in the 30-untranslated region of
many proto-oncogenes, growth factors and cytokine mRNAs
(Chen and Shyu, 1995; Jacobson and Peltz, 1996). Multiple copies
of the sequence, AUUUA, often exist in the ARE and they target
ARE-mRNAs for rapid degradation (Chen and Shyu, 1995;
Brennan and Steitz, 2001). Numerous proteins are known to
interact with AREs and modulate either the stabilisation or
destabilisation of ARE-mRNAs (Chen and Shyu, 1995; Jacobson
and Peltz, 1996; Antic and Keene, 1997; Brennan and Steitz, 2001).
Among such proteins, HuR binds to AREs to protect ARE-mRNAs
from rapid degradation (Brennan and Steitz, 2001).
In the cells transformed by an adenovirus oncogene product,
ARE-mRNAs and their associated proteins, such as HuR and pp32,
are exported to the cytoplasm in a CRM1-independent manner
(Higashino et al, 2005). Therefore it is interesting to investigate the
export pathway of ARE-mRNA and its binding partner proteins in
non-virus-mediated tumour cells.
In this study, we provide evidence regarding the export of HuR
to the cytoplasm in oral cancer cells. We found that ARE-mRNA
was also simultaneously exported and accumulated in these cells
and that leptomycin B (LMB) treatment failed to inhibit the HuR
export. These data indicate that HuR and ARE-mRNAs are
exported to the cytoplasm in oral cancer cells in a manner
different from that of normal cells. In addition, these findings
indicate that this HuR export can be used as a diagnostic marker
for oral cancers.
MATERIALS AND METHODS
Cells and cell fractionation
Human oral cancer cells, HSC-3 (a human tongue squamous cell
carcinoma cell line) and Ca9.22 (a human gingival squamous cell
carcinoma cell line), and human oral normal cells, human gingival
fibroblast (HGF) and periodontal ligament (PDL) cells, were
cultured at 371C with 5% CO2 in DMEM (Nissui Seiyaku, Tokyo,
Japan) containing 10% foetal bovine serum with penicillin/
streptomycin (Sigma, St Louis, MO, USA). Some of these cells
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swere treated with heat shock (451C, 1h) and some were treated
with LMB (Sigma) (5ngml
 1) for 7h.
Cell fractionation was carried out by separating the cells into
cytoplasmic and nuclear fractions, as previously described (Weigel
and Dobbelstein, 2000), by harvesting and re-suspending the cells in a
fractionating buffer (10mM Tris-HCl, pH 7.6; 150mM NaCl; 1.5mM
MgCl2 and 0.5% Nonidet P-40 (Sigma-Aldrich, St Louis, MO, USA),
protease inhibitor cocktail), followed by vigorous shaking for 5min
and centrifugation at 12000r.p.m. for 30s. The supernatant was used
as the cytoplasmic fraction. To estimate the accuracy of cell frac-
tionation, cytoplasmic protein, b-tubulin (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), and nuclear protein, Lamin A/C (Santa Cruz),
were detected by immunoblotting.
Immunohistochemical and immunofluorescence analyses
Tissue samples were obtained from excised tongue carcinomas of
patients at the Hokkaido University Dental Hospital, Hokkaido,
Japan, and from normal tongue tissues. Informed consent was
obtained from the patients before the samples were used. Immuno-
histochemical detection of HuR was carried out using the avidin–
biotin complex method as previously described (Shindoh et al, 1996).
Cells were fixed with 4% formaldehyde, permeabilised with 0.1%
Triton X-100 and incubated with antibodies specific to HuR (Santa
Cruz). After incubation with HuR-specific antibodies, the cells
were again incubated with FITC-conjugated secondary antibodies
(Molecular Probes, Carlsbad, CA, USA). The cells were observed
using an OLYMPUS IX71 (Olympus, Tokyo, Japan) fluorescence
microscope.
Western blot analysis
Western blot analysis was performed using antibodies specific to
HuR (Santa Cruz), b-tubulin, Lamin A/C, CRM1 (BD Biosciences,
San Jose, CA, USA) and b-actin (Sigma), as previously described
(Aoyagi et al, 2003).
Quantitative real-time RT–PCR
To determine the quantity of ARE-mRNAs, the cells were treated
with TRI REAGENT (Sigma), after which their RNA was subjected
to reverse transcription using Rever Tra Ace (TOYOBO, Osaka,
Japan). For quantitative real-time RT–PCR analysis, amplification
was performed in a DNA Engine-Opticon 2 PCR machine (MJ
Research, Waltham, MA, USA) with SYBR Green PCR master mix
(DyNAmo SYBR Green qPCR Kit, MJ Research) as previously
described (Higashino et al, 2005).
To evaluate the half-life of c-myc mRNA, HSC-3 and HGF cells
were treated with actinomycin D (Act.D) (Sigma) (5mgml
 1) for
30 or 60min. The extracted RNA was subjected to quantitative
real-time RT–PCR.
In situ hybridisation
In situ hybridisation was performed according to a previously
described method (Higashino et al, 2005). The cells were fixed in
cold 3% formaldehyde and permeabilised with cold 0.5% Triton
X-100. Hybridisation was performed overnight at 371Ci n2 0mlo fa
mixture containing 2.5mg of tRNA, 10mg of salmon sperm DNA,
2 SSC, 0.2% BSA, 1mM vanadyl ribonucleoside complexes, 50%
formamide, 10% dextran sulphate and 10–30ng of 30-digoxigenin
(DIG)-labelled anti-sense deoxyoligonucleotide probe (Hokkaido
System Science, Sapporo, Hokkaido, Japan) for c-fos or c-myc
mRNA. The coverslips were washed thrice with 2 SSC (Invitrogen,
Carlsbad, CA, USA) at 371C and thereafter with 1 SSC at room
temperature. After washing, they were incubated for 60min at
room temperature with a dilution of 1:50 of anti-DIG fluorescein
Fab fragments (Roche, Basel, Switzerland) in 0.2% Triton X-100/
PBS containing 1% BSA (Sigma). After incubation, the coverslips
were washed twice with 0.2% Triton X-100/PBS and thereafter with
only PBS. The probes (sense and anti-sense) used were comple-
mentary to the nucleotides 288–328 of c-fos and to the nucleotides
6278–6311 of c-myc. Nuclei of the cells were stained using DAPI
(40,60diamidino-2-phenylindole) (Roche).
HuR knockdown
To knockdown HuR, siRNA was transfected using RNAiMAX
(Invitrogen) as per the manufacturer’s instructions. The
knockdown level of HuR mRNA was analysed by western blot
analysis. HuR siRNA was 50-uuaccaguuucaauggucatt-30, and
the control siRNA was Silencer Negative Control #1 siRNA
(Invitrogen).
RESULTS
Localisation of HuR in oral cancer cells
To determine the subcellular localisation of HuR in oral cancer
cells, we carried out an immunohistochemical analysis of HuR
using oral cancer cells, HSC-3 (tongue carcinoma) and Ca9.22
(gingival carcinoma) cells, and normal oral cells, HGF and PDL
cells. In HSC-3 and Ca9.22 cells, both the cytoplasm and the
nucleus were positively stained by HuR antibody, whereas in HGF
and PDL cells, only the nucleus was stained (Figure 1A). These
data suggest that HuR is localised in the nucleus and cytoplasm of
the oral cancer cells, whereas almost all of it is localised in the
nucleus of normal cells.
Thereafter, we stained the oral cancer tissue (tongue carcinoma)
with the same antibody, which showed a cytoplasmic staining
of HuR (Figure 1B, arrows) as against the nuclear staining
observed in the adjacent normal cells. In contrast, HuR was localised
in the nucleus in normal tissues (Figure 1B). These data indicate the
fact that HuR is present in the cytoplasm of oral cancer cells.
To confirm the cytoplasmic localisation of HuR, the cells were
separated into cytoplasmic and nuclear fractions, and the HuR of
each fraction was detected by western blotting. The amounts of
HuR in the cytoplasm of HSC-3 and Ca9.22 cells were much higher
than those observed in the cytoplasm of normal cells (Figure 1C).
These results also suggest that HuR is localised in the cytoplasm of
oral cancer cells.
Together, these results indicate that HuR is present in the
nucleus of normal cells as well as in both the nucleus and the
cytoplasm of oral cancer cells, which further suggest that HuR is
exported to the cytoplasm in oral cancer cells.
Export and stabilisation of ARE-mRNAs in oral cancer
cells
We examined the export of ARE-mRNA in oral cancer cells, as ARE-
mRNA is known to be exported to the cytoplasm with its binding
partner HuR (Brennan et al, 2000; Higashino et al,2 0 0 5 ) .T h e
subcellular localisation of c-fos and c-myc mRNAs in oral cancer
cells (HSC-3 and Ca9.22) and in normal cells (HGF) was confirmed
by in situ hybridisation. These mRNAs were detected in the nucleus
and cytoplasm of HSC-3 and Ca9.22 cells, but were localised only in
the nucleus of HGF cells (Figure 2A). These data suggest the export
of ARE-mRNAs to the cytoplasm in oral cancer cells.
It has been previously reported that the exported ARE-mRNA is
stabilised in the cells transformed with adenovirus E4orf6
(Higashino et al, 2005). In this study, we also examined the
stabilisation of ARE-mRNA in oral cancer cells. The amount of
c-myc mRNA expressed in oral cancer (HSC-3 and Ca9.22) and
normal (HGF) cells was measured by quantitative real-time
RT–PCR. Accumulation of the ARE-mRNAs was greater in the
HSC-3 and Ca9.22 oral cancer cells than in the normal cells
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s(Figure 2B). Moreover, to compare the half-life of c-myc mRNA,
HSC-3 and HGF cells were treated with Act.D, and then the
quantity of c-myc mRNA was measured by real-time RT–PCR. The
half-life of the mRNA in HSC-3 cells was longer than that of HGF
cells (Figure 2B). These results suggest the stabilisation of ARE-
mRNA in oral cancer cells.
To explore the role of HuR for the export and stabilisation of
ARE-mRNA in cancer cells, HSC-3 cells were subjected to HuR
knockdown. In HuR-knockdown cells, c-myc mRNA was in the
nucleus or in the perinuclear region, although the mRNA existed in
both the cytoplasm and the nucleus (Figure 2C). In addition, the
quantity of c-myc mRNA decreased in the HuR-knockdown cells
compared with that in the cells transfected with the control siRNA
(Figure 2C). These results indicate that the export and the
increased accumulation of c-myc mRNA are indeed because of
HuR in oral cancer cells.
Export of HuR in the presence of LMB
HuR is known to be exported to the cytoplasm in a manner
dependent on CRM1, which is a member of the exportin family of
nuclear transporters, when cells are stimulated by heat shock or
serum stimulation (Brennan et al, 2000; Gallouzi and Steitz, 2001).
On the other hand, HuR and ARE-mRNAs are known to be
exported to the cytoplasm through a CRM1-independent pathway
in cells transformed by an adenovirus oncogene product
(Higashino et al, 2005). To study the export pathway of HuR in
oral cancer cells, an immunofluorescence analysis of the cancer
HSC-3 Ca9.22 A
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HSC-3 Ca9.22 HGF
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Figure 1 Subcellular localisation of HuR in oral cancer cells. (A) Immunohistochemical detection of HuR in oral cancer (HSC-3 and Ca9.22) and normal
(HGF and PDL) cells. (B) Immunohistochemical detection of HuR in human oral cancer (tongue carcinoma, arrows) and normal oral tissues. Representative
photomicrographs of HuR expression in both tissues are shown at  200 magnification. (C) Western blot analysis of the nuclear and cytoplasmic fractions
of HSC-3, Ca9.22 and HGF cells using HuR and b-actin antibodies. The fractions were analysed by antibodies against b-tubulin and Lamin A/C. Quantitative
assessment of HuR protein in each fraction is shown as a histogram. Hold changes in the HuR level as measured by densitometry is shown.
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scells, to examine the localisation of HuR, was carried out after their
treatment with LMB, an inhibitor of CRM1. In normal cells, heat
shock treatment induced stress granules (SGs), which include
HuR, and LMB treatment reduced HuR-included SGs (Figure 3A).
Conversely, the accumulation of HuR to the cytoplasm in the oral
cancer cells was not inhibited, even after the cells were treated with
LMB for 7h (Figure 3A).
To further confirm the effect of LMB, the existence of HuR in the
cytoplasm was examined by western blotting. In normal HGF cells,
HuR was observed in the cytoplasm after heat shock treatment
(451C, 1h), but the HuR band was not visible in the lysate of the
cells treated with LMB before the heat shock. On the other hand, in
HSC-3 cells, HuR was observed in the cytoplasm even after the
cells were treated with LMB (Figure 3B). Together, these data
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Figure 2 Export and stabilisation of ARE-mRNAs in oral cancer cells. (A) The distribution of c-fos and c-myc mRNAs in HSC-3, Ca9.22 and HGF were
detected by in situ hybridisation using digoxigenin-labelled anti-sense (upper) and sense (lower) probes complementary to c-fos and c-myc mRNAs. The
DAPI-stained nuclei are shown. (B) The accumulation of c-myc mRNAs expressed in each cell was measured by quantitative real-time RT–PCR (upper).
Each cell was treated with Act.D and the amount of c-myc mRNA was estimated at the indicated time by quantitative real-time RT–PCR (lower). Data are
mean±s.e.m. of three independent experiments. (C) The localisation (upper) and accumulation (lower) of c-myc mRNA in HuR-knockdown HSC-3 cells.
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sindicate that, in oral cancer cells, the quantity of HuR in the
cytoplasms appeared to be unchanged at least 7h treatment of
LMB, and that HuR is exported to the cytoplasm by perturbing the
physiological CRM-dependent export machinery.
DISCUSSION
This study shows that HuR and ARE-mRNAs are exported to the
cytoplasm in oral cancer cells, and that ARE-mRNA accumulates
in these cells. In addition, this study also shows that LMB fails to
inhibit the accumulation of HuR in the cytoplasm of oral cancer
cells. These results indicate that HuR and ARE-mRNAs are
exported from the nucleus to the cytoplasm in oral cancer cells
in a manner different from that of normal cells, and that this HuR
export can be used as a diagnostic marker for oral cancer.
Cytoplasmic HuR expression has been implicated in the
malignancy of several types of carcinomas, such as colon, ovary,
breast, salivary, uterus, larynx and prostate cancers, and has been
postulated to contribute towards the cancerous malignant
phenotype (Erkinheimo et al, 2003; Lo ´pez de Silanes et al, 2003,
2005; Denkert et al, 2004; Heinonen et al, 2005; Cho et al, 2007a,b;
Niesporek et al, 2008). Our observations regarding the HuR export
to the cytoplasm in oral cancer cells are similar to those previously
reported in other types of carcinomas, and are thus in agreement
with previous research. However, the relationship between the
cytoplasmic HuR expression and the malignancy of oral carcinoma
has not been established so far.
Although HuR is exported to the cytoplasm in a CRM1-
independent manner in the cells transformed by an adenovirus
oncogene product (Higashino et al, 2005), the HuR export pathway
in non-virus-mediated cancer cells has never been investigated.
Although the possibility that HuR had been exported and
accumulated in the cytoplasm before the LMB treatment is still
remaining, the inability of LMB to inhibit the HuR export in oral
cancer cells, proves that the export pathway is not CRM1-
dependent. The exact mechanism of HuR export in cancer cells
is yet to be determined, but our results show that it occurs in a
mechanism different from that of normal cells. Besides CRM1,
Trn1 and Trn2 are other important nuclear export receptors that
have been implicated in mediating the transport of HuR (Rebane
et al, 2004). This gives rise to questions regarding the involvement
of the Trn pathway in HuR export in oral cancer cells.
The AMP-activated protein kinase contributes towards the
nuclear import of HuR (Wang et al, 2002), MAPK-activated
protein kinase 2 increases the cytoplasmic level of HuR (Tran et al,
2003) and Protein kinase C facilitates the export of HuR to the
cytoplasm by phosphorylation of HuR (Doller et al, 2007, 2008).
Thus, phosphorylation of HuR is important for its localisation in
the cells. Moreover, recently, HuR has been shown to be
phosphorylated by Cdk1 during the G2 phase, and is retained as
phosphorylated HuR in the nucleus in association with the 14-3-3
protein (Kim et al, 2008). Although the status of HuR phospho-
rylation in cancer cells has never been elucidated, HuR phospho-
rylation might be abnormal, which could provide valuable insights
into understanding its export mechanism.
ACKNOWLEDGEMENTS
We thank Mariko Aoyagi for her technical advice on in situ
hybridisation and real-time RT–PCR. This work was supported in
part by a Grant-in-Aid for Scientific Research from the Ministry of
Education, Science and Culture of Japan.
REFERENCES
Antic D, Keene JD (1997) Embryonic lethal abnormal visual RNA-binding
proteins involved in growth, differentiation, and posttranscriptional gene
expression. Am J Hum Genet 61: 273–278
Aoyagi M, Higashino F, Yasuda M, Takahashi A, Sawada Y, Totsuka Y,
Kohgo T, Sano H, Kobayashi M, Shindoh M (2003) Nuclear export
of the adenovirus E4orf6 protein is necessary for its ability to
antagonize the apoptotic activity of the BH3-only proteins. Oncogene
22: 6919–6927
Brennan CM, Gallouzi IE, Steitz JA (2000) Protein ligands to HuR modulate
its interaction with target mRNAs in vivo. J Cell Biol 151: 1–14
Brennan CM, Steitz JA (2001) HuR and mRNA stability. Cell Mol Life Sci 58:
266–277
Chen CY, Shyu AB (1995) AU-rich elements: characterization
and importance in mRNA degradation. Trends Biochem Sci 20:
465–470
Cho NP, Han HS, Soh Y, Lee KY, Son HJ (2007a) Cytoplasmic HuR over-
expression is associated with increased cyclooxygenase-2 expression in
laryngeal squamous cell carcinomas. Pathology 39: 545–550
Cho NP, Han HS, Soh Y, Son HJ (2007b) Overexpression of cyclooxy-
genase-2 correlates with cytoplasmic HuR expression in salivary
mucoepidermoid carcinoma but not in pleomorphic adenoma. J Oral
Pathol Med 36: 297–303
Denkert C, Weichert W, Pest S, Koch I, Licht D, Ko ¨bel M, Reles A, Sehouli J,
Dietel M, Hauptmann S (2004) Overexpression of the embryonic-lethal
abnormal vision-like protein HuR in ovarian carcinoma is a prognostic
factor and is associated with increased cyclooxygenase 2 expression.
Cancer Res 64: 189–195
Doller A, Akool el-S, Huwiler A, Mu ¨ller R, Radeke HH, Pfeilschifter J,
Eberhardt W (2008) Posttranslational modification of the AU-rich
element binding protein HuR by protein kinase Cdelta elicits angiotensin
HGF A
B
No treatment HS LMB (+) HS+LMB (+)
HSC-3 LMB(+) Ca9.22 LMB(+)
HuR
DAPI HuR DAPI HuR
+ –
HSC3
-Actin
Heat shocked
HGF
: LMB 
HGF
+ – + –
HuR
Figure 3 Role of CRM1 in the export of HuR in oral cancer cells.
(A) The effect of LMB on the export of HuR was observed by an
immunofluorescence analysis using HuR antibody. The HGF cells treated
with heat shock in the presence and absence of LMB are shown (upper).
HuR localisation in the LMB-treated HSC-3 and Ca9.22 cells, stained with
DAPI are shown. (lower) (B) The same cells used in panel A were
separated into nuclear and cytoplasmic fractions, and the amount of
cytoplasmic HuR was confirmed by western blotting.
HuR export in oral cancer cells
H Hasegawa et al
1947
British Journal of Cancer (2009) 100(12), 1943–1948 & 2009 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sII-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.
Mol Cell Biol 28: 2608–2625
Doller A, Huwiler A, Mu ¨ller R, Radeke HH, Pfeilschifter J, Eberhardt W
(2007) Protein kinase C alpha-dependent phosphorylation of the mRNA-
stabilizing factor HuR: implications for posttranscriptional regulation of
cyclooxygenase-2. Mol Biol Cell 18: 2137–2148
Erkinheimo TL, Lassus H, Sivula A, Sengupta S, Furneaux H, Hla T,
Haglund C, Butzow R, Ristima ¨ki A (2003) Cytoplasmic HuR expression
correlates with poor outcome and with cyclooxygenase 2 expression in
serous ovarian carcinoma. Cancer Res 63: 7591–7594
Fan XC, Steitz JA (1998) HNS, a nuclear-cytoplasmic shuttling sequence in
HuR. Proc Natl Acad Sci USA 95: 15293–15298
Gallouzi IE, Brennan CM, Steitz JA (2001) Protein ligands mediate the
CRM1-dependent export of HuR in response to heat shock. RNA 7:
1348–1361
Gallouzi IE, Steitz JA (2001) Delineation of mRNA export pathways by the
use of cell-permeable peptides. Science 294: 1895–1901
Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux
H, Hla T, Haglund C, Ristima ¨ki A (2005) Cytoplasmic HuR expression is
a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65:
2157–2161
Higashino F, Aoyagi M, Takahashi A, Ishino M, Taoka M, Isobe T,
Kobayashi M, Totsuka Y, Kohgo T, Shindoh M (2005) Adenovirus E4orf6
targets pp32/LANP to control the fate of ARE-containing mRNAs by
perturbing the CRM1-dependent mechanism. J Cell Biol 170: 15–20
Jacobson A, Peltz SW (1996) Interrelationships of the pathways of mRNA
decay and translation in eukaryotic cells. Annu Rev Biochem 65: 693–739
Kim HH, Abdelmohsen K, Lal A, Pullmann Jr R, Yang X, Galban S,
Srikantan S, Martindale JL, Blethrow J, Shokat KM, Gorospe M (2008)
Nuclear HuR accumulation through phosphorylation by Cdk1. Genes
Dev 22: 1804–1815
Lo ´pez de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES,
Gorospe M (2003) Role of the RNA-binding protein HuR in colon
carcinogenesis. Oncogene 22: 7146–7154
Lo ´pez de Silanes I, Lal A, Gorospe M (2005) HuR: post-transcriptional
paths to malignancy. RNA Biol 2: 11–13
Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H (1996) Cloning and
characterization of HuR, a ubiquitously expressed Elav-like protein.
J Biol Chem 99: 8144–8151
Niesporek S, Kristiansen G, Thoma A, Weichert W, Noske A, Buckendahl
AC, Jung K, Stephan C, Dietel M, Denkert C (2008) Expression of the
ELAV-like protein HuR in human prostate carcinoma is an indicator
of disease relapse and linked to COX-2 expression. Int J Oncol 32:
341–347
Rebane A, Aab A, Steitz JA (2004) Transportins 1 and 2 are redundant
nuclear import factors for hnRNP A1 and HuR. RNA 10: 590–599
Shindoh M, Higashino F, Kaya M, Yasuda M, Funaoka K, Hanzawa M, Hida
K, Kohgo T, Amemiya A, Yoshida K, Fujinaga K (1996) Correlated
expression of matrix metalloproteinases and ets family transcription
factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.
Am J Pathol 148: 693–700
Tran H, Maurer F, Nagamine Y (2003) Stabilization of urokinase and
urokinase receptor mRNAs by HuR is linked to its cytoplasmic
accumulation induced by activated mitogen-activated protein kinase-
activated protein kinase 2. Mol Cell Biol 23: 7177–7188
Wang W, Fan J, Yang X, Fu ¨rer-Galban S, Lopez de Silanes I, von Kobbe C,
Guo J, Georas SN, Foufelle F, Hardie DG, Carling D, Gorospe M (2002)
AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22:
3425–3436
Weigel S, Dobbelstein M (2000) The nuclear export signal within the E4orf6
protein of adenovirus type 5 supports virus replication and cytoplasmic
accumulation of viral mRNA. J Virol 74: 764–772
HuR export in oral cancer cells
H Hasegawa et al
1948
British Journal of Cancer (2009) 100(12), 1943–1948 & 2009 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
s